The new facility, which has been brought online on schedule, has a state of the art 930 m^2^; ISO class 7 cleanroom for the manufacture of single-use systems.

Validation of the facility was completed in mid-April and the plant is currently manufacturing products for its bio-pharmaceutical and pharmaceutical clients.

"While we had envisaged marking this day with a ribbon cutting ceremony to recognize the efforts of all those involved in bringing this new facility online, this is obviously not possible given Covid-19," said Nigel Cannon, managing director of the new site. "This symbolic day will come, but what is of immediate importance, perhaps now more than ever given the current health crisis, is that Meissner has an additional operational manufacturing facility capable of supplying our clients with products critical to the manufacture of life saving medicines including those directly related to Covid-19."

Meissner\'s new manufacturing facility is over 3900 m^2^ and future expansion plans will see this increase over the coming years. Initial groundwork for this expansion is set to begin later this year. Meissner anticipated future expansions at the time of purchasing the new Advanced Technology Building from the IDA, the non-commercial, semi-state body promoting foreign direct investment into Ireland, by also buying the adjacent land.

For further information, visit [www.meissner.com](http://www.meissner.com){#interrefs10}
